Business
Newron Announces AGM 2026 Results
MILAN, ITALY - April 23, 2026 (NEWMEDIAWIRE) - Newron Pharmaceuticals S.p.A. ("Newron") (SIX: NWRN, XETRA: NP5), a biopharmaceutical company focused on the development of novel therapies for patients with diseases of the central and peripheral ner...
About this update from Newron Pharmaceuticals S.p.a.
View the original release on www.newmediawire.com
View stock analysis, news, and events for Newron Pharmaceuticals S.p.a.